BCAL Diagnostics is an Australian-owned, ASX listed, biotechnology company. They are pioneering and distributing non-invasive blood tests designed to provide patients with greater confidence in their care. BCAL believes early and accurate detection is key to improving cancer outcomes.
| Website | http://bcaldiagnostics.com |
| Revenue | $5.1 million |
| Employees | 22 (16 on RocketReach) |
| Founded | 2010 |
| Address | 4 Cornwallis St, Eveleigh, New South Wales 2015, AU |
| Technologies |
JavaScript
,
HTML
,
Twitter
+10 more
(view full list)
|
| Industry | Biotechnology Research, Medical Testing & Clinical Laboratories, Healthcare |
| Keywords | Womens Health Screening, Biotechnology, Biotech, Health Diagnostics, Healthcare Technology, Medical Diagnostics, Asx Listed, Diagnostic Tests, Preventative Healthcare, Affordable Healthcare, Medical Technology, Accessible Healthcare, Safe Healthcare, Cost Effective Healthcare, Early Detection, Innovative Healthcare, Disease Screening |
| Competitors | Cleveland Clinic, Exact Sciences, Guardant Health, GRAIL, Foundation Medicine, Invitae, Genomic Health, Biocept, Inc., FreeScape Inc, carisls +38 more (view full list) |
| SIC | SIC Code 80 Companies, SIC Code 807 Companies |
| NAICS | NAICS Code 6215 Companies, NAICS Code 62151 Companies, NAICS Code 621 Companies, NAICS Code 62 Companies |
Looking for a particular BCAL Diagnostics employee's phone or email?
The BCAL Diagnostics annual revenue was $5.1 million in 2026.
Annie Arnett is the CEO of BCAL Diagnostics.
16 people are employed at BCAL Diagnostics.
BCAL Diagnostics is based in Eveleigh, New South Wales.
The NAICS codes for BCAL Diagnostics are [6215, 62151, 621, 62].
The SIC codes for BCAL Diagnostics are [80, 807].